Back to search

Cornell University

BIOACTIVE THERAPIES FOR DEGENERATIVE DISC DISEASE

Abstract

dc:description.abstract

The intervertebral disc (IVD) is a fibrocartilaginous and composite tissue structure located between adjacent vertebrae with remarkable resiliency to cyclic loading. The IVD is comprised of a gelatinous hydrated core called the nucleus pulposus (NP) and is tightly held by rings of concentric collagen fibers called the annulus fibrosus (AF). Its unique composition and structure enable spinal stability, flexibility, and shock absorption from everyday movement. Over time, the progressive breakdown of the IVD due to age, injury, or illness results in the onset of degenerative disc disease (DDD). Eventually, this leads to weakening of the AF and depletion of disc extracellular matrix (ECM) components, resulting in poor load bearing capacity, reduced flexibility, recurrent pain, and profound disability. In fact, DDD and subsequent lower back pain is the leading cause of disability globally. Although biochemical changes are well documented in the degenerative IVD, current treatments are palliative and prioritize pain management as a means to delay surgical intervention. Moreover, surgical treatments fail to restore both native IVD composition and structure. With this in mind, the overarching goal of this dissertation is to develop bioactive and cell-based therapeutics for clinically relevant presentations of DDD. Chapter 1 reviews the challenges and innovations in developing bioactive therapies for early-stage degeneration, herniation, and end-stage degeneration. Chapter 2 investigates the safety and efficacy of intradiscal bone marrow aspirate concentrate (BMAC) injections following lumbar microdiscectomy in a phase 1 pilot study. Chapter 3 leverages a large animal model to investigate the capacity of a flexible support material to maintain disc height and support the formation of hydrated tissue engineered intervertebral discs (TE-IVDs) for total disc replacement. Chapter 4 employs CRISPR gene editing technology to regulate stem cell fate and enhance tissue deposition in composite TE-IVDs. Altogether, these findings represent a true bench-to-bedside approach, taking bioactive therapies from in vitro and in vivo studies to the assessment of their safety and efficacy in human patients.

Degree

thesis:*
Name thesis:degree_name
Ph. D., Biomedical Engineering
Level thesis:degree_level
Doctor of Philosophy
Discipline thesis:degree_discipline
Biomedical Engineering
Grantor
Cornell University
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Fidai, Alikhan
Chair dc:contributor.chair
  • Bonassar, Lawrence
Committee members dc:contributor.committeemember
  • Putnam, David
  • Delco, Michelle

Subjects

dc:subject × 4

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*
Dc Identifier Bibid
17422665
Dc Identifier Other
ProQuest Submission ID: 15192
ProQuest Publication ID: 32169722

Chain of custody

source
Harvested from
Cornell University
Base URL
ecommons.cornell.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Fidai, Alikhan. BIOACTIVE THERAPIES FOR DEGENERATIVE DISC DISEASE. Doctor of Philosophy thesis, Cornell University, 2025. https://hdl.handle.net/1813/120765